Anticoagulants Market Study Report 2021-2027 | Bristol-Myers Sqiubb, Amphastar Pharmaceutical, Sanofi, Hepalink group, Pfizer

The anticoagulants market is anticipated to register expansive growth ascribed to its mounting need in the treatment of coronary artery and atrial fibrillation/flutter diseases. Several governments across the globe are taking in initiatives to spread awareness regarding coronary diseases. According to CDC (Centers for Disease Control and Prevention), around 1.0 million individuals were affected by coronary events in the U.S. in 2019, of which 0.3 million were recurrent coronary and 0.7 million new events.

Organizations like the National Institutes of Health (NIH) and CDC are also undertaking several initiatives regarding awareness such disease. However, mounting prevalence of the disease could subsequently upsurge the adoption of anticoagulant products, expanding its overall supply and production.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/4967

Global Market Insights, Inc., reckons that the anticoagulants market size is anticipated to surpass USD 51.9 billion by 2027 at a growth rate of 6.4%.

Some of the prominent companies functioning in the anticoagulants market include Sanofi, Bristol-Myers Sqiubb, Pfizer, Laboratories Farmaceuticos Rovi SA, Amphastar Pharmaceutical, Leo Pharma, Hepalink group, among others. These industry players are emphasizing on taking strategic initiatives such as new product launches, acquisitions, and business expansion to strengthen their market presence. In 2018, ROVI had announced the marketing of its enoxaparin biosimilar in Spain, helping the company expand its geographical presence as well as increased revenue from product sales.

The Asia Pacific anticoagulant industry is expected to grow at a rate of 7.9% during the forecast timeframe. Increasing number of chronic disease cases could propel the demand for the anticoagulants market in the region. Strong presence of patients in highly populated countries such as India and China has favored anticoagulant businesses.

The Asia Pacific Thrombosis Advisory Board report claims that cardiovascular diseases were considered as one of the most common disorders in the Asian population in the year 2019. The incidence rate of myocardial infarction and coronary heart disease was approximately 150 per 100,000 population per annum added the report. Along with this, the presence of numerous local manufacturers in Southeast Asia may expand the Asia Pacific anticoagulants market development.

Request for customization @ https://www.gminsights.com/roc/4967

Considering application, the anticoagulants market is bifurcated into atrial fibrillation/flutter, venous thromboembolism, coronary artery disease, and others. The venous thromboembolism segment is expected to show significant growth in the estimated timeframe as it accounted for USD 1.9 billion in 2020. Increasing pervasiveness of venous thromboembolism is anticipated to contribute to segment growth. Rising awareness regarding venous thromboembolism will drive the segment demand hence anticipating market growth in the future.

Partial Chapter of the Table of Content

Chapter 4. Anticoagulants Market, By Drug Class

4.1. Key segment trends

4.2. Factor Xa inhibitor

4.2.1. Market size, by region, 2016 - 2027 (USD Million)

4.3. Heparin

4.3.1. Market size, by region, 2016 - 2027 (USD Million)

4.4. Warfarin

4.4.1. Market size, by region, 2016 - 2027 (USD Million)

4.5. Direct thrombin inhibitor

4.5.1. Market size, by region, 2016 - 2027 (USD Million)

4.6. Others

4.6.1. Market size, by region, 2016 - 2027 (USD Million)

Chapter 5. Anticoagulants Market, By Route of Administration

5.1. Key segment trends

5.2. Oral

5.2.1. Market size, by region, 2016 - 2027 (USD Million)

5.3. Injectable

5.3.1. Market size, by region, 2016 - 2027 (USD Million)

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/anticoagulants-market

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

This release was published on openPR.